Mk-677 Research Chemical
MK-677 (Ibutamoren) is an orally active, non-peptide growth hormone secretagogue extensively investigated in preclinical research models. This guide provides an analytical overview of its receptor kinetics, biochemical targets, preclinical findings, laboratory solubility standards, and rigorous quality verification protocols required for laboratory experimentation.
Quick answer
MK-677 (Ibutamoren) is an orally active, non-peptide growth hormone secretagogue extensively investigated in preclinical research models. This guide provides an analytical overview of its receptor kinetics, biochemical targets, preclinical findings, laboratory solubility standards, and rigorous quality verification protocols required for laboratory experimentation.
Key takeaways
- The MK-677 research chemical, also known as Ibutamoren mesylate, is a non-peptide, orally bioavailable growth hormone secretagogue that selectively targets the ghrelin receptor (GHS-R1a).
- At the cellular level, the [MK-677 research chemical](/product/mk-677) functions as a potent, synthetic agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), a G-protein-coupled receptor primarily expressed in the hypothalamus and anterior pituitary gland.
- In vitro data and animal research models demonstrate that exposure to MK-677 induces a marked amplification of endogenous growth hormone pulses.
- To properly contextualize the operational parameters of the MK-677 research chemical, comparative analyses with other somatotropic ligands are essential.
What is the MK-677 Research Chemical?
The MK-677 research chemical, also known as Ibutamoren mesylate, is a non-peptide, orally bioavailable growth hormone secretagogue that selectively targets the ghrelin receptor (GHS-R1a). In laboratory research settings, MK-677 is evaluated for its capacity to stimulate sustained, pulsatile growth hormone (GH) and insulin-like growth factor 1 (IGF-1) elevation through ghrelin-receptor activation without significantly disrupting basal cortisol or prolactin levels.
Unlike peptide-based somatotropic agents that require parenteral administration or exhibit short biological half-lives, MK-677 represents a spiroindoline compound developed to maintain structural stability in physiological solutions. As a small molecule, it serves as a critical reference tool in endocrine studies, metabolic assays, and cellular signaling investigations examining the somatotropic axis.
Molecular Structure and Ghrelin Receptor (GHS-R1a) Binding
At the cellular level, the MK-677 research chemical functions as a potent, synthetic agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), a G-protein-coupled receptor primarily expressed in the hypothalamus and anterior pituitary gland. By binding to GHS-R1a, MK-677 mimics the endogenous ligand ghrelin, initiating an intracellular signaling cascade mediated by phospholipase C and inositol trisphosphate (IP3).
This signal transduction pathway triggers a transient release of intracellular calcium from the endoplasmic reticulum, stimulating the exocytosis of growth hormone storage vesicles from pituitary somatotrophs. Preclinical binding assays indicate that MK-677 displays high receptor affinity (Ki ≈ 0.4 nM), allowing researchers to investigate long-term pituitary responsiveness and somatotroph activation patterns in growth hormone secretagogues research models.
Preclinical Literature: GH and IGF-1 Axis Activation
In vitro data and animal research models demonstrate that exposure to MK-677 induces a marked amplification of endogenous growth hormone pulses. In canine and rodent models, systemic administration leads to sustained increases in plasma GH concentrations, followed by elevated secondary transcription of hepatic IGF-1. The physiological consequence of this dual-biomarker surge is a central focus of investigations into muscle tissue homeostasis and nitrogen balance.
Crucially, literature reviews highlighting growth hormone secretagogue mechanisms emphasize that MK-677 preserves the natural pulsatility of pituitary secretion. Unlike direct recombinant GH exposure, which can cause total downregulation of endogenous feedback loops, MK-677 maintains the dynamic feedback interplay between somatostatin and growth hormone-releasing hormone (GHRH) in preclinical subjects.
Comparative Analysis: MK-677 vs. Injectable Secretagogues
To properly contextualize the operational parameters of the MK-677 research chemical, comparative analyses with other somatotropic ligands are essential. In preclinical assays, secretagogues are frequently differentiated by structural class, half-life, pathway selectivity, and route of administration in animal test models.
While MK-677 is a non-peptide small molecule displaying an extended elimination half-life (~24 hours in animal pharmacokinetic models), peptide-based agents such as Ipamorelin exhibit rapid clearance profiles requiring precise administration timing. Similarly, modified GHRH analogs like CJC-1295 NO DAC act on the GHRH receptor rather than GHS-R1a, producing distinct intracellular cAMP cascades. First-generation hexapeptides such as GHRP-6 engage the ghrelin receptor but carry higher rates of cross-reactivity with prolactin and ACTH release compared to the tighter receptor binding profile of MK-677.
Metabolic and Anabolic Biomarker Investigation
In preclinical model systems, researchers utilize MK-677 to analyze nitrogen retention under caloric restriction or catabolic stress. In rodent studies involving induced nitrogen deficit, administration of MK-677 was shown to restore positive nitrogen balance, demonstrating its potential utility in studying sarcopenia and muscle-wasting pathophysiology.
Furthermore, animal assays measuring bone turnover markers reveal that long-term treatment with MK-677 elevates biomarkers of bone formation, such as osteocalcin and serum alkaline phosphatase. Researchers investigating musculoskeletal degradation models regularly cross-reference these findings across our full catalog of all research peptides and small molecules to assess synergistic cellular signaling pathways.
Solubility, Preparation, and Storage Parameters
Proper laboratory handling is critical to preserving the structural integrity and batch uniformity of the MK-677 research chemical. As a solid compound (typically provided as a mesylate salt), MK-677 displays excellent solubility in organic solvents and aqueous buffers optimized for cell culture or animal model delivery.
Standard laboratory preparation protocols recommend dissolving MK-677 in dimethyl sulfoxide (DMSO) or ethanol, achieving concentrations up to 25 mg/mL under gentle vortexing. For aqueous in vitro assays, master stock solutions prepared in DMSO can be further diluted into phosphate-buffered saline (PBS), ensuring final organic solvent concentrations remain below target cellular toxicity thresholds (<0.1% v/v). Lyophilized raw powder should be stored at -20°C in a desiccated, light-protected environment to prevent hydrolytic degradation.
Analytical Quality Verification: RP-HPLC, MS, and Endotoxin Testing
In vitro research validity depends entirely on compound purity and batch consistency. Low-grade research chemicals containing unreacted precursors, organic impurities, or bacterial endotoxins introduce confounding variables that invalidate experimental data.
At PX1 Research, every batch of the MK-677 research chemical undergoes comprehensive quality control testing in an ISO 17025 accredited laboratory. Chemical identity and purity are verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) paired with Electrospray Ionization Mass Spectrometry (ESI-MS), ensuring chemical purity exceeding 98.0%. Furthermore, compounds undergo Chromogenic Limulus Amebocyte Lysate (LAL) testing to confirm endotoxin levels strictly meet ultra-low laboratory standards (<0.01 EU/mg).
Sourcing High-Purity Research Compounds from PX1 Research
PX1 Research serves as a premier, USA-manufactured supplier dedicated exclusively to supporting academic, biotechnology, and institutional laboratories. Every lot of our MK-677 research chemical is processed in GMP-compliant facilities and accompanied by a downloadable, lot-specific Certificate of Analysis (COA) detailing exact HPLC chromatograms, mass spectral data, and endotoxin metrics.
To prevent project delays, PX1 Research maintains full stock availability with same-day dispatch on orders placed Monday through Friday, shipping directly from our state-of-the-art logistics facilities located in California and Arizona. Research institutions requiring larger volume quantities or recurring supply pipelines can access customized terms through our dedicated wholesale research account portal.
Biosafety Standards and Preclinical Laboratory Protocols
The MK-677 research chemical is supplied strictly as a reagent for in vitro, biochemical, and preclinical laboratory research. It is not intended, designed, or cleared for human consumption, clinical application, or veterinary therapeutic use. Principal investigators and laboratory personnel must adhere to standard Biosafety Level 1 or 2 containment protocols when handling the compound.
Personal protective equipment (PPE), including nitrile gloves, safety goggles, and laboratory coats, must be worn during solution preparation and weighing procedures. Chemical waste, surplus solutions, and contaminated consumables must be disposed of in accordance with regional hazardous waste management regulations and institutional biosafety guidelines.
Frequently Asked Questions
What is the primary biological target of the MK-677 research chemical?
MK-677 acts as a selective, potent agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), mimicking the endogenous hormone ghrelin to stimulate pituitary growth hormone release.
Is MK-677 classified as a peptide?
No. MK-677 (Ibutamoren mesylate) is a non-peptide small molecule with high oral bioavailability, setting it apart structurally from peptide secretagogues like Ipamorelin or Sermorelin.
How is chemical purity verified for PX1 Research compounds?
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm peak area integration above 98%, alongside Mass Spectrometry (MS) to verify molecular mass and structure.
What solvents are suitable for dissolving MK-677 in laboratory assays?
MK-677 is soluble in organic solvents including DMSO, ethanol, and PEG-400. Stock solutions can be diluted into aqueous buffers such as PBS for specific assay configurations.
What are the recommended long-term storage conditions for raw powder?
Lyophilized or solid state MK-677 powder should be stored at -20°C in a sealed container with a desiccant, protected from direct light and ambient humidity.
Does PX1 Research perform endotoxin testing on small molecules like MK-677?
Yes. Every batch undergoes LAL assay testing to confirm endotoxin levels are maintained below strict analytical limits (<0.01 EU/mg) to prevent non-specific immune responses in cell cultures.
Can MK-677 be compared directly to GHRH analogs in research protocols?
Yes, but researchers should account for distinct receptor targets: MK-677 targets GHS-R1a, whereas GHRH analogs like Sermorelin target the GHRH receptor, generating different secondary messenger cascades.
How quickly do orders for research chemicals ship from PX1 Research?
Orders placed Monday through Friday before cut-off times ship same-day from our dual distribution centers in California and Arizona.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.